This study will evaluate niraparib, a type of targeted therapy known as a PARP inhibitor. Niraparib will be combined with trastuzumab, an anti-
Niraparib is a medication used to treat ovarian cancer. It may cause serious side effects such as bleeding, infection, and low blood counts. Learn about the most common and less common side effects of niraparib and how to report them to the FDA.
Niraparib generic Niraparib is prescribed as a maintenance treatment in adult patients with recurrent epithelial ovarian cancer, fallopian tube cancer
Ninlaro (Ixazomib Citrate) Niraparib Tosylate Monohydrate Niraparib Tosylate Trexall (Methotrexate Sodium) Trifluridine and Tipiracil Hydrochloride
Niraparib may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away: nausea vomiting constipation
niraparib as maintenance therapy experienced more time without certain side effects than those who received placebo. Niraparib, a PARP
Niraparib has the potential to cause effects on pulse rate and blood pressure in patients side effects. The Canada Vigilance Program does not
Report a suspected side effect or falsified product to the MHRA Yellow Card scheme. Moderate hepatic impairment did not have an effect on niraparib Cmax or on
Side Effects of Niraparib. Below are common side effects that have been known to happen in about one third or more of patients taking niraparib are listed on
Comments
one of my own pet peeves, sorry
The story was awesome...
Given all the side effects of mostly untested medications I could honestly see this happening to someone since most new meds get pulled within 5 years because of the side effects.